Secretory leucoprotease inhibitor binds to NF-κB binding sites in monocytes and inhibits p65 binding

Documenti analoghi

• Secretory Leucoprotease Inhibitor Impairs Toll-Like Receptor 2- and 4-Mediated Responses in Monocytic Cells
  di: Greene, Catherine M., et al.
  Pubblicazione: (2004)
• Decreased Levels of Secretory Leucoprotease Inhibitor in the Pseudomonas-infected Cystic Fibrosis Lung are due to Neutrophil Elastase Degradation()
  di: Weldon, Sinéad, et al.
  Pubblicazione: (2009)
• The Ability of Secretory Leukocyte Protease Inhibitor to Inhibit Apoptosis in Monocytes Is Independent of Its Antiprotease Activity
  di: Niamh McGarry, et al.
  Pubblicazione: (2015-01-01)
• The Ability of Secretory Leukocyte Protease Inhibitor to Inhibit Apoptosis in Monocytes Is Independent of Its Antiprotease Activity
  di: McGarry, Niamh, et al.
  Pubblicazione: (2015)
• Quantification and Evaluation of the Role of Antielastin Autoantibodies in the Emphysematous Lung
  di: Low, Teck Boon, et al.
  Pubblicazione: (2011)